The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Developmental and Reproductive Toxicology (DART) Services Market Research Report 2025

Global Developmental and Reproductive Toxicology (DART) Services Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1739103

No of Pages : 86

Synopsis
Global Developmental and Reproductive Toxicology (DART) Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Developmental and Reproductive Toxicology (DART) Services market research.

Key companies engaged in the Developmental and Reproductive Toxicology (DART) Services industry include Inotiv, Accelera, Charles River, AnaPath Services, Frontage, WuXi AppTec, Creative Animodel, Pharmaron and Labcorp, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Developmental and Reproductive Toxicology (DART) Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Developmental and Reproductive Toxicology (DART) Services market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Developmental and Reproductive Toxicology (DART) Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Inotiv
  • Accelera
  • Charles River
  • AnaPath Services
  • Frontage
  • WuXi AppTec
  • Creative Animodel
  • Pharmaron
  • Labcorp
  • RCC
  • Creative Biolabs
  • IITRI
  • Syngene
  • JOINN

Segment by Type

  • Fertility and Early Embryonic Development (FEED) study
  • Embryofetal Development (EFD) study
  • Pre- and Post-natal (PPND) study
  • Others

Segment by Application

  • Biotechnology
  • Academic Research
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Developmental and Reproductive Toxicology (DART) Services report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fertility and Early Embryonic Development (FEED) study
1.2.3 Embryofetal Development (EFD) study
1.2.4 Pre- and Post-natal (PPND) study
1.2.5 Others
1.3 Market by Application
1.3.1 Global Developmental and Reproductive Toxicology (DART) Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biotechnology
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Developmental and Reproductive Toxicology (DART) Services Market Perspective (2018-2029)
2.2 Developmental and Reproductive Toxicology (DART) Services Growth Trends by Region
2.2.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Developmental and Reproductive Toxicology (DART) Services Historic Market Size by Region (2018-2023)
2.2.3 Developmental and Reproductive Toxicology (DART) Services Forecasted Market Size by Region (2024-2029)
2.3 Developmental and Reproductive Toxicology (DART) Services Market Dynamics
2.3.1 Developmental and Reproductive Toxicology (DART) Services Industry Trends
2.3.2 Developmental and Reproductive Toxicology (DART) Services Market Drivers
2.3.3 Developmental and Reproductive Toxicology (DART) Services Market Challenges
2.3.4 Developmental and Reproductive Toxicology (DART) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Developmental and Reproductive Toxicology (DART) Services Players by Revenue
3.1.1 Global Top Developmental and Reproductive Toxicology (DART) Services Players by Revenue (2018-2023)
3.1.2 Global Developmental and Reproductive Toxicology (DART) Services Revenue Market Share by Players (2018-2023)
3.2 Global Developmental and Reproductive Toxicology (DART) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Developmental and Reproductive Toxicology (DART) Services Revenue
3.4 Global Developmental and Reproductive Toxicology (DART) Services Market Concentration Ratio
3.4.1 Global Developmental and Reproductive Toxicology (DART) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Developmental and Reproductive Toxicology (DART) Services Revenue in 2022
3.5 Developmental and Reproductive Toxicology (DART) Services Key Players Head office and Area Served
3.6 Key Players Developmental and Reproductive Toxicology (DART) Services Product Solution and Service
3.7 Date of Enter into Developmental and Reproductive Toxicology (DART) Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Developmental and Reproductive Toxicology (DART) Services Breakdown Data by Type
4.1 Global Developmental and Reproductive Toxicology (DART) Services Historic Market Size by Type (2018-2023)
4.2 Global Developmental and Reproductive Toxicology (DART) Services Forecasted Market Size by Type (2024-2029)
5 Developmental and Reproductive Toxicology (DART) Services Breakdown Data by Application
5.1 Global Developmental and Reproductive Toxicology (DART) Services Historic Market Size by Application (2018-2023)
5.2 Global Developmental and Reproductive Toxicology (DART) Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size (2018-2029)
6.2 North America Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2018-2023)
6.4 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Developmental and Reproductive Toxicology (DART) Services Market Size (2018-2029)
7.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2018-2023)
7.4 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size (2018-2029)
8.2 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Developmental and Reproductive Toxicology (DART) Services Market Size (2018-2029)
9.2 Latin America Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2018-2023)
9.4 Latin America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size (2018-2029)
10.2 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Inotiv
11.1.1 Inotiv Company Detail
11.1.2 Inotiv Business Overview
11.1.3 Inotiv Developmental and Reproductive Toxicology (DART) Services Introduction
11.1.4 Inotiv Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.1.5 Inotiv Recent Development
11.2 Accelera
11.2.1 Accelera Company Detail
11.2.2 Accelera Business Overview
11.2.3 Accelera Developmental and Reproductive Toxicology (DART) Services Introduction
11.2.4 Accelera Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.2.5 Accelera Recent Development
11.3 Charles River
11.3.1 Charles River Company Detail
11.3.2 Charles River Business Overview
11.3.3 Charles River Developmental and Reproductive Toxicology (DART) Services Introduction
11.3.4 Charles River Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.3.5 Charles River Recent Development
11.4 AnaPath Services
11.4.1 AnaPath Services Company Detail
11.4.2 AnaPath Services Business Overview
11.4.3 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Introduction
11.4.4 AnaPath Services Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.4.5 AnaPath Services Recent Development
11.5 Frontage
11.5.1 Frontage Company Detail
11.5.2 Frontage Business Overview
11.5.3 Frontage Developmental and Reproductive Toxicology (DART) Services Introduction
11.5.4 Frontage Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.5.5 Frontage Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Detail
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Introduction
11.6.4 WuXi AppTec Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.6.5 WuXi AppTec Recent Development
11.7 Creative Animodel
11.7.1 Creative Animodel Company Detail
11.7.2 Creative Animodel Business Overview
11.7.3 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Introduction
11.7.4 Creative Animodel Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.7.5 Creative Animodel Recent Development
11.8 Pharmaron
11.8.1 Pharmaron Company Detail
11.8.2 Pharmaron Business Overview
11.8.3 Pharmaron Developmental and Reproductive Toxicology (DART) Services Introduction
11.8.4 Pharmaron Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.8.5 Pharmaron Recent Development
11.9 Labcorp
11.9.1 Labcorp Company Detail
11.9.2 Labcorp Business Overview
11.9.3 Labcorp Developmental and Reproductive Toxicology (DART) Services Introduction
11.9.4 Labcorp Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.9.5 Labcorp Recent Development
11.10 RCC
11.10.1 RCC Company Detail
11.10.2 RCC Business Overview
11.10.3 RCC Developmental and Reproductive Toxicology (DART) Services Introduction
11.10.4 RCC Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.10.5 RCC Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Detail
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Introduction
11.11.4 Creative Biolabs Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.11.5 Creative Biolabs Recent Development
11.12 IITRI
11.12.1 IITRI Company Detail
11.12.2 IITRI Business Overview
11.12.3 IITRI Developmental and Reproductive Toxicology (DART) Services Introduction
11.12.4 IITRI Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.12.5 IITRI Recent Development
11.13 Syngene
11.13.1 Syngene Company Detail
11.13.2 Syngene Business Overview
11.13.3 Syngene Developmental and Reproductive Toxicology (DART) Services Introduction
11.13.4 Syngene Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.13.5 Syngene Recent Development
11.14 JOINN
11.14.1 JOINN Company Detail
11.14.2 JOINN Business Overview
11.14.3 JOINN Developmental and Reproductive Toxicology (DART) Services Introduction
11.14.4 JOINN Revenue in Developmental and Reproductive Toxicology (DART) Services Business (2018-2023)
11.14.5 JOINN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’